WWIO .0005 Falling HUGE 8-K OUT >> Current Report Filing

New Post Public Reply Private Reply Replies (0) Message Board
MoneyMaker
WWIO .0005 Falling HUGE 8-K OUT >> Current Report Filing (8-k)

Source: Edgar (US Regulatory)

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): April 29, 2015

 

Wowio, Inc.

(Exact name of registrant as specified in its charter)

 

Texas 333-184529  27-2908187 (State or Other Jurisdiction 
of Incorporation)  (Commission 
File Number) (I.R.S. Employer 
Identification Number)

  

626 North Doheny Drive

West Hollywood, CA 90069

(Address of principal executive offices) (zip code)

 

(310) 807-8181

 (Registrant's telephone number, including area code)

 

_________

(Former name, if changed since last report.)

 

Copies to:

Gina Austin, Esq.

Arden Anderson, Esq.

Austin Legal Group, APC

3990 Old Town Avenue, Suite A-112

San Diego, California 92110

Phone: (619) 924-9600

Fax: (619) 881-0045

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

[  ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[  ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[  ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[  ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

  

 

 

 

 

 

Item 8.01Other Events

 

An informational letter, in the form filed herewith as Exhibit 99.1, is being transmitted to our shareholders on the date hereof.

 

Attached as Exhibit 99.1 is the Company’s Letter to Shareholders dated April 29, 2015

 

Item 9.01Financial Statements and Exhibits

 

(d) Exhibits.

 

The exhibits listed in the following Exhibit Index are filed as part of this Current Report on Form 8-K.

 

Exhibit No .Description  99.1Letter to Shareholders dated April 29, 2015.

 

 

 

  

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 WOWIO, INC.   Dated: April 30, 2015By:/s/ Brian Altounian Name:Brian Altounian Title:Chief Executive Officer

 

 

 

 



 

LETTER TO SHAREHOLDERS

April 29, 2015

 

Dear Shareholders, Investors and Friends,

 

As we are well on our way into 2015, we are working on a number of fronts to achieve our goal of increasing shareholder value. Over the past year, we have entered into and announced numerous financing arrangements to clean up our balance sheet. While we have faced challenges with market capitalization, we don’t feel that market share price adequately reflects the true intrinsic value in our company, our technology, or our intellectual property. The market and the timing for our technology, our platform and other planned development is maturing – media consumers have wholly changed the way television content is being consumed, the way film studios market and distribute their films, the way music is being discovered and delivered and the way print media is now distributing content. Our technology development has endured several pivots while we assess the best way to address this dynamic change in digital delivery mechanisms. Mobile delivery of apps is significantly different than online delivery of product. With all of that in mind, we are trying to address several different methods and modes of delivery and we are looking at other ways to exploit our intellectual property including our library of proprietary content, our publishing business and digital media initiatives. To that end, we are making great strides with our technology development and intellectual property licensing efforts and we wanted to share some of that progress with you here.

 

1) On the technology development side, we are a couple weeks out from delivering our online and mobile platform. Here are a couple of sneak peek screen shots of that development:

 

 

 

 

 

 

 

 

Our tech development partners at Eminosoft are working diligently to get this platform finalized and populated with properties, initially from the WOWIO library and soon to include libraries from our publishing partners. Readers will have the option of paying for the books or downloading for free with an ad-supported model, utilizing our patented process for delivering ads based on user demographics. We are thrilled to finally be able to launch this on the Android operating system first, reaching over 1 billion worldwide users.

 

2) In addition, we have made our eBook library available for purchase and download online through our Carthay Circle Publishing site at http://www.carthaycirclepublishing.com. Here’s a screenshot of what you’ll find there.

 

 

 

Titles include WOWIO Classics, comics from the SpaceDog Library, the new Beatles multi-media ebooks and other Carthay Circle titles. We will be looking to expand this library over the next 12 – 18 months. Details of this library expansion will be revealed soon.

 

3) We are developing a new kind of eBook reader that we believe will be revolutionary in the eBook space. Without giving too much detail away, this will take advantage of social media engagement within a private group or in a broader, more public environment. This application will allow readers to interact with one another as well as comment, post, tweet, blog about books the way they currently do with film, movies, music, etc. We don’t have a timeline yet for deployment but this is something we have had on our development timetable for quite some time.

 

 

 

 

4) In some exciting news, our hardware partners at Akyumen Technologies have successfully obtained FCC Certification for their hardware device, a projector phone currently named The Hawk, and the company is making plans for distribution of their tablets and smartphones, both with built-in projectors, in various territories throughout the world, including the United States. Link to the FCC Grant can be found here: http://fccid.net/number.php?fcc=2ADLD-HAWK01&...z3W5JckqJo. WOWIO’s eBook platform, ad-insertion technology will be pre-loaded on every Akyumen device in distribution, which is set to begin this fall.

 

5) Finally, on the IP monetization plans, the company has begun discussions with a number of partners to monetize the creative content owned by WOWIO. Announcements on agreements will be made soon. The patent monetization plans include detailed research on potential licensing partners and the Company has been in discussions with its legal team to begin pursuit of discussions with those potential licensees.

 

Thank you for your ongoing support of the Company and we look forward to sharing news and information as we progress down these exciting paths.

 

-The WOWIO/StudioW Team

 

Safe Harbor Statement

 

Matters discussed in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. These include, but are not limited to, risks and uncertainties associated with: the impact of economic, competitive and other factors affecting the Company and its operations, markets, product, and distributor performance, the impact on the national and local economies resulting from terrorist actions, and U.S. actions subsequently; and other factors detailed in reports filed by the Company. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Any forward-looking statement made by us in this release is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

 

 

 

 

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 237

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 176

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 228

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
CapCut's AI Tools Reshape Video Content Creation

Updated Category News Views 143

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 344

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 0

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

Updated Category News Views 188

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 81

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 138

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 92

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading

Top 5 Most Recently Viewed Articles

Oasis Management Proposes Governance Change for Kobayashi Pharma

Updated Category News Views 243

Oasis Management Advocates for Enhanced Governance at Kobayashi Pharma Oasis Management Company Ltd. (“Oasis”) has emerged as a significant voice among shareholders of Kobayashi Pharmaceutical Co., Ltd. (4967 JT). Holding over 7.5% of the company, Oasis is actively pushing for essential changes in leadership and independent oversight to address pressing governance...

Continue Reading
Synopsys Faces Legal Challenges Amid Stockholder Concerns

Updated Category News Views 235

Understanding the Recent Class Action Lawsuit Against Synopsys Recently, concerns have emerged regarding Synopsys, Inc. as a class action lawsuit was filed alleging serious misrepresentations concerning the company’s financial health. Investors who have been affected are encouraged to seek guidance to explore their legal rights and options that may arise from this...

Continue Reading
Cumulus Media's Engaging Coverage of 2025 NCAA Basketball Events

Updated Category News Views 228

Thrilling NCAA Basketball Coverage by Cumulus Media Cumulus Media’s Westwood One is gearing up for an exciting audio experience during the 2025 NCAA Men’s and Women’s Basketball tournaments. With the largest radio network in the country, Westwood One will deliver comprehensive coverage that connects die-hard sports fans across a plethora of platforms. Connecting...

Continue Reading
ByteDance's Ambitious AI Chip Investment Plans for 2025

Updated Category News Views 1644

ByteDance's Strategic Investment in AI Technology ByteDance, the renowned owner of TikTok, is making significant strides in artificial intelligence by planning to invest more than $12 billion on AI infrastructure in the upcoming years. This ambitious investment highlights the company's commitment to harnessing cutting-edge technology for growth. According to reports, the...

Continue Reading
Investors of ModivCare, Inc. Urged to Join Class Action Lawsuit

Updated Category News Views 130

Investors of ModivCare, Inc. Urged to Join Class Action Lawsuit The law firm Robbins Geller Rudman & Dowd LLP is calling for investors of ModivCare, Inc. (NASDAQ: MODV) who have experienced significant financial losses to take action. Understanding the Class Action Lawsuit The upcoming class action lawsuit, titled Kalera v. ModivCare, Inc., brings serious allegations...

Continue Reading